CLINICAL_TRIALS
trial_result
· 2016-03-21
Clinical Trial Update: Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome. [Phase 2]
Summary
Phase 2 trial evaluating incobotulinumtoxinA (Xeomin) for relief of restless legs syndrome symptoms has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Restless Leg Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-03-21